Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001144204-18-007440

10% owner bought 600,000 shares at $162,660.00 ($97,596,000,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mayne Pharma Ventures Pty Ltd 10% owner 2017-12-19 Purchase +600,000 $162,660.00 $97,596,000,000 198,106,132 D
Open-market purchases · 600,000 sh · avg $162,660.00 · $97,596,000,000
Loading xslF345X03/tv485756_4.xml…